Burdett Buckeridge & Young

BBY Limited, originally established as Burdett Buckeridge & Young, was a prominent Australian stockbroking and investment banking firm headquartered in Sydney. Founded in 1988, the firm became one of the largest independent brokers in Australia, providing corporate advisory, equity capital markets, and institutional research services. BBY was notably active in the life sciences and biotechnology sectors, acting as a key financier and advisor for numerous Australian healthcare IPOs and secondary offerings. The firm was instrumental in the capital-raising efforts of several high-profile biotech companies before its financial collapse. BBY entered voluntary administration in May 2015 and subsequently underwent liquidation, marking one of the most significant failures in the Australian financial services industry.